Absci Corporation (ABSI)
Upgrades & Downgrades
Latest ABSI news
Absci to Participate in Upcoming Investor Conferences
28 August 2023
VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the follo...
The 3 Most Undervalued Penny Stocks to Buy Now: August 2023
14 August 2023
Penny stocks are often defined as stocks trading under $5 per share, those with a very low price per share or market capitalization, and are generally higher-risk. Now, despite many such stocks certai...
Beyond OpenAI: 7 promising startups that have saved lives, sped up drug development and improved man...
1 June 2023
OpenAI is stealing the spotlight as the definitive artificial-intelligence startup — for now. Backed by Microsoft Corp. MSFT, the progenitor of ChatGPT-4 has become the focus of the AI wave, but other...
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
15 May 2023
Absci Corporation (ABSI) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.33 per share a year ago.
Absci Takes Its Generative AI Antibody Design Platform To Europe
28 February 2023
Generative AI technology, like ChatGPT, is disrupting many industries including biopharma. For example, Absci is using AI to design & validate de novo antibodies.
Publicly traded biotech company Absci lays off employees, citing ‘macro-economic conditions'
10 August 2022
5 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
9 August 2022
Let us look at some drug/biotech stocks, ABSI, AXLA, FRLN, DICE and PLRX, which are poised to beat on second-quarter earnings.
Here's Why Absci Corp Shares Are Falling
23 March 2022
Absci Corp (NASDAQ: ABSI) shares are trading lower by 9.2% at $6.79 after the company reported fourth-quarter earnings results. Absci reported quarterly losses of 28 cents per share.
Absci to Present at Global AI Conference NVIDIA GTC
16 March 2022
VANCOUVER, Wash., March 16, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a drug and target discovery company harnessing deep learning, AI and synthetic biology to expand the therapeutic ...